Study Reveals How Diet, Antioxidants Prevent Blindness In Aging Population
Main Category: Seniors / AgingAlso Included In: Nutrition / Diet; Eye Health / Blindness
Article Date: 20 Aug 2008 - 3:00 PDT
| Patient / Public: | ![]() |
4 (8 votes) |
| Healthcare Prof: | ![]() |
3 (3 votes) |
A new study reveals part of the magic behind a diet rich in antioxidants, showing how artichokes, blueberries and pecans can hold at bay the leading cause of age-related blindness in developed countries.
Researchers discovered a link between two processes in the retina that, in combination, contribute to a disease called macular degeneration. They found antioxidants disrupt the link and extend the lifetime of irreplaceable photoreceptors and other retinal cells.
"The implication is that people at risk of macular degeneration could help prevent the disease by consuming antioxidants," said Heidi Vollmer-Snarr, a Brigham Young University chemist who earned a doctorate from Oxford and began work on this disease as a postdoctoral researcher at Columbia.
The study is online and will be published in an upcoming issue of the Journal of Biological Chemistry. Vollmer-Snarr collaborated with researchers at Weill Medical College of Cornell University.
Age-related macular degeneration affects more than 1.75 million people in the United States. With a rapidly aging population, that number will rise to 3 million by 2020. People struck with the disease first lose central vision and temporarily adjust by relying more on peripheral vision. Some eventually lose their vision entirely.
Dr. Paul Bernstein of the University of Utah's Moran Eye Center says understanding the exact mechanisms of macular degeneration has remained elusive. Bernstein was not involved in the study.
"This work by Dr. Vollmer-Snarr and colleagues ties these two damaging processes together and demonstrates the harm they cause in combination is much more than would be expected," Bernstein said. "This new knowledge suggests the possibility of interventions which could prove to be powerful ways to prevent or delay age-related macular degeneration."
The new study finds a destructive synergy between the buildup of a compound called A2E and damage to cellular "power plants" called mitochondria. A2E is a natural byproduct of cellular activity that, unlike other compounds, won't break down or be disposed by the body.
A problem occurs when A2E encounters oxidative stress created by light exposure. In these circumstances, A2E disrupts energy production in mitochondria. The resulting energy shortage pulls the plug on daily cleaning and maintenance of photoreceptors and another type of retinal cell.
The result is more A2E buildup, and the cycle of destruction hastens the death of these vital visual cells, which are not replaced when they die. The experiments performed with visual cells from rats, cows and humans showed that antioxidants could completely counter the damage.
Seeing this process play out in the retina has given Vollmer-Snarr a novel idea for attacking harmful growths in the body. The strategy would involve delivering potentially disruptive compounds like A2E to the target and then using light to trigger the damage.
"Why not take a page out of one disease's book in the fight against other diseases?" Vollmer-Snarr said.
BYU graduate student Junping Gao is also a co-author on the study. Joining as co-authors are Cornell medical researchers Silvia C. Finnemann, Cristofol Vives-Bauza, Monika Anand, Arash K. Shirazi, Jordi Magrane and Giovanni Manfredi.
Brigham Young University
C-327 ASB
Provo, UT 84602
United States
http://www.byu.edu
Visit our seniors / aging section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/118747.php>
APA
http://www.medicalnewstoday.com/releases/118747.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




